Our Team
Our team are clinicians with backgrounds in health governance, regulation, management, leadership, finance and clinical service delivery. We have a detailed understanding of health care. KP Health’s team of expert clinical consultants excel in delivering health consulting services to address technically complex clinical challenges.
KP Health’s team of expert clinical consultants specialise in large, technically complex clinical and public health projects.
Our passion
Our Director, Dr Paul Woodhouse, is passionate about making a difference to the health sector.
Get in touch with us today to learn more about our expert health consulting services.

Dr Paul Woodhouse, Director
MBBS, BMedSc, MBA, DBA, AFRACMA, FAMA
Paul founded KP Health with Kelly Shaw In 2013. Paul is a respected medical manager with an unparalleled understanding of the complex relationships between hospitals and clinicians. His areas of expertise in health consultancy include health systems organisation and programs, public hospital and health financing, quality of care, and resource allocation.
Paul also has extensive experience in performance management, clinical risk management, government relations and health sector industrial relations. Paul has undertaken a range of projects in the areas of services evaluation, policy, planning and governance in the health, ageing and disability sectors.
Paul is recognised for his ability to analyse clinical datasets with an insight which reflects his thorough understanding of clinical and administrative practice.

Dr Kelly Shaw
MBBS, MPH, PhD, FRACGP, FAFPHM, GAICD
Kelly is a public health physician, epidemiologist and clinician. She is an experienced healthcare consultant with exceptional skills in evidence review, program development and evaluation, and health technology review and assessment.

Amber Polles
BPharm, MBA, AA, CP
Amber is a pharmacist with high level experience in hospital and community pharmacy practice. Amber is nationally recognised by her peers, her areas of expertise include quality use of medicines, medication management systems, medicines evaluation and pharmacy service review.
Amber is respected for her strong understanding of medicines and pharmacy practice together with her experience in pharmaceutical contracting, policy, and access programs to support cost effective use of medicines.
Amber particularly enjoys working with stakeholders to develop strategies to improve health programs and services. Her areas of expertise in consultancy include evidence review for medication safety and efficacy, service evaluation, stakeholder engagement and models of care.

Dr Hanni Gennat
Dip App Sci, BSc, PhD
Hanni is a physiologist, sports scientist and clinical researcher. Her areas of expertise include population health, obesity, chronic disease and multimorbidity, cardiovascular disease, lifestyle risk factors and complementary medicines.
Hanni is respected for her work in systematic literature reviews and guideline development, and has conducted numerous literature reviews for the National Health and Medical Research Council.
Hanni has published a number of textbooks in physiology and in evidence-based complementary medicines and herb-drug interactions. She also has multiple publications in peer-reviewed literature, including for the Cochrane Library.

Alex Kitsos
B Pthy (Hons) M Med Stat
Alex is a physiotherapist and biostatistician who specialises in the analysis of large, complex health datasets and linked health data.
Alex’s clinical background affords him a detailed understanding of the clinical relevance and implications of findings from his analyses, providing a more effective service to clinicians, researchers, health managers and policymakers.
Alex is passionate about improving using health data to improve outcomes for people living with chronic conditions. His analyses inform our understanding of chronic disease epidemiology, and geospatial and sociodemographic trends.
Alex is respected for his deep insights into communicable diseases epidemiology and projections. He is sought after for his analytical skills into COVID-19 modelling and trends
